Business Description
Pangen Biotech Inc
ISIN : KR7222110009
Compare
Compare
Traded in other countries / regions
222110.Korea IPO Date
2016-03-11Description
Pangen Biotech Inc is a biotechnology company. It is engaged in development of biosimilar products and technology transfer services for biologics development. It develops biosimilar products, such as EPO, recombinant factor VIII, G-CSF, etc.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.63 | |||||
| Equity-to-Asset | 0.71 | |||||
| Debt-to-Equity | 0.13 | |||||
| Debt-to-EBITDA | 1.78 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 3.91 | |||||
| Beneish M-Score | -2.05 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 2.1 | |||||
| 3-Year EBITDA Growth Rate | -10.1 | |||||
| 3-Year EPS without NRI Growth Rate | 2.9 | |||||
| 3-Year FCF Growth Rate | 13.3 | |||||
| 3-Year Book Growth Rate | -7.2 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 55.36 | |||||
| 9-Day RSI | 48.84 | |||||
| 14-Day RSI | 48.23 | |||||
| 3-1 Month Momentum % | 52.15 | |||||
| 6-1 Month Momentum % | 10.12 | |||||
| 12-1 Month Momentum % | 1.47 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.3 | |||||
| Quick Ratio | 1.77 | |||||
| Cash Ratio | 1.3 | |||||
| Days Inventory | 308.51 | |||||
| Days Sales Outstanding | 51.33 | |||||
| Days Payable | 12.96 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.5 | |||||
| Shareholder Yield % | -7.55 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 38.63 | |||||
| Operating Margin % | -0.5 | |||||
| Net Margin % | -4.36 | |||||
| FCF Margin % | 13.11 | |||||
| ROE % | -3.8 | |||||
| ROA % | -2.53 | |||||
| ROIC % | -0.35 | |||||
| 3-Year ROIIC % | 4.79 | |||||
| ROC (Joel Greenblatt) % | -1.77 | |||||
| ROCE % | -1.16 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 4.49 | |||||
| PB Ratio | 3.45 | |||||
| Price-to-Tangible-Book | 4.18 | |||||
| Price-to-Free-Cash-Flow | 34.06 | |||||
| Price-to-Operating-Cash-Flow | 82.52 | |||||
| EV-to-EBIT | -297.35 | |||||
| EV-to-EBITDA | 49.05 | |||||
| EV-to-Revenue | 4.59 | |||||
| EV-to-FCF | 36.22 | |||||
| Price-to-GF-Value | 0.46 | |||||
| Price-to-Net-Current-Asset-Value | 7.64 | |||||
| Earnings Yield (Greenblatt) % | -0.34 | |||||
| FCF Yield % | 2.69 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Pangen Biotech Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 13,723.638 | ||
| EPS (TTM) (â‚©) | -83 | ||
| Beta | 0.49 | ||
| 3-Year Sharpe Ratio | -0.07 | ||
| 3-Year Sortino Ratio | -0.12 | ||
| Volatility % | 42.94 | ||
| 14-Day RSI | 48.23 | ||
| 14-Day ATR (â‚©) | 446.672641 | ||
| 20-Day SMA (â‚©) | 5546 | ||
| 12-1 Month Momentum % | 1.47 | ||
| 52-Week Range (â‚©) | 3750 - 7770 | ||
| Shares Outstanding (Mil) | 12.63 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Pangen Biotech Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Pangen Biotech Inc Stock Events
| Event | Date | Price (â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Pangen Biotech Inc Frequently Asked Questions
What is Pangen Biotech Inc(XKRX:222110)'s stock price today?
The current price of XKRX:222110 is â‚©5280.00. The 52 week high of XKRX:222110 is â‚©7770.00 and 52 week low is â‚©3750.00.
When is next earnings date of Pangen Biotech Inc(XKRX:222110)?
The next earnings date of Pangen Biotech Inc(XKRX:222110) is .
Does Pangen Biotech Inc(XKRX:222110) pay dividends? If so, how much?
Pangen Biotech Inc(XKRX:222110) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers